Breaking News Instant updates and real-time market news.

SGEN

Seattle Genetics

$64.52

0.5 (0.78%)

09:36
06/19/17
06/19
09:36
06/19/17
09:36

Seattle Genetics price target lowered to $48 from $57 at Piper Jaffray

Piper Jaffray analyst Edward Tenthoff lowered his price target for Seattle Genetics to $48 after the company announced the discontinuation of the Phase III Cascade trial in acute myeloid leukemia. The analyst views the news as a negative surprise and removed SGN-CD33A from his model. He keeps a Neutral rating on Seattle Genetics. The stock in early trading is down 9%, or $5.62, to $58.90.

SGEN Seattle Genetics
$64.52

0.5 (0.78%)

02/13/17
RBCM
02/13/17
NO CHANGE
RBCM
Seattle Genetics drug acquisition would be positive, says RBC Capital
After Seattle Genetics (SGEN) announced a global development and license agreement with Immunomedics (IMMU) for sacituzumab, RBC Capital analyst Adnan Butt says that the drug "seems approvable," given the positive data it has generated in trials involving triple negative breast cancer patients. The analyst adds that the drug significantly reduces the risk posed by the stock and could be used to treat other cancers. He notes that the deal has not yet been completed and keeps an $80 price target and an Outperform rating on the stock.
02/13/17
FBCO
02/13/17
NO CHANGE
Target $66
FBCO
Neutral
Seattle Genetics price target raised to $66 from $62 at Credit Suisse
Credit Suisse analyst Kennen MacKay raised his price target for Seattle Genetics to $66 from $62 saying he views the company's bid for Immunomedics' IMMU-132 positively. The analyst sees potential for near-term accelerated submission and potential approval in 2018 with potential for blockbuster sales. MacKay assumes a 60% probability of deal closing as Immunomedics has potential to seek additional bids. He reiterates a Neutral rating on Seattle Genetics' shares.
03/15/17
OPCO
03/15/17
INITIATION
OPCO
Perform
Seattle Genetics initiated with a Perform at Oppenheimer
Oppenheimer analyst Leah Rush Cann initiated Seattle Genetics with a Perform rating, expecting Seattle Genetics will continue to develop its commercial drug, Adcetris, which is already approved for Hodgkin lymphoma.
05/05/17
05/05/17
UPGRADE

Outperform
Immunomedics upgraded at Wells Fargo after Seattle Genetics deal terminated
As previously reported, Wells Fargo analyst Jim Birchenough upgraded Immunomedics (IMMU) to Outperform from Market Perform, stating that he is impressed at how quickly the new board moved to secure financing needed to advance IMMU132 and to put in place new management. With improved leadership, a better cash position and the Seattle Genetics (SGEN) deal terminated, Birchenough expects Immunomedics to secure "more appropriate" partnership terms for its "competitive asset for solid tumors," he tells investors. He increased his price target range for Immunomedics shares to $10-$11.50 from $5-$6.

TODAY'S FREE FLY STORIES

RGA

Reinsurance Group

$126.86

-0.36 (-0.28%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Reinsurance Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

SRCL

Stericycle

$77.24

-1.01 (-1.29%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Stericycle management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 03

    Aug

THO

Thor Industries

$107.33

-1.47 (-1.35%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Thor Industries management to meet with Cancaccord »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 06

    Jul

IDCC

InterDigital

$79.80

-0.65 (-0.81%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
InterDigital management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

NP

Neenah Paper

$77.80

-1.6 (-2.02%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Neenah Paper management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

AGCO

AGCO

$66.47

-0.67 (-1.00%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
AGCO management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Aug

04:55
06/28/17
06/28
04:55
06/28/17
04:55
General news
Pending Home Sales Index to be reported at 10:00 »

May Pending Home Sales…

PRTS

U.S. Auto Parts

$3.23

-0.02 (-0.62%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
U.S. Auto Parts management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
JPMorgan life sciences analyst holds an analyst/industry conference call »

Life Science Tools &…

STE

STERIS

$81.47

-1.64 (-1.97%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
STERIS management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

VTR

Ventas

$71.17

-0.76 (-1.06%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Ventas management to meet with Raymond James »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

SMTC

Semtech

$34.85

-0.6 (-1.69%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Semtech management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

IVZ

Invesco

$34.77

-0.24 (-0.69%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Invesco management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

DHXM

DHX Media

$4.30

0.15 (3.61%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
DHX Media management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

04:55
06/28/17
06/28
04:55
06/28/17
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

May International Trade…

PODD

Insulet

$49.00

-1.22 (-2.43%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Insulet participates in a conference call with Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

NFG

National Fuel

$55.85

-0.45 (-0.80%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
National Fuel management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

OXY

Occidental Petroleum

$59.63

-0.38 (-0.63%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Occidental Petroleum management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

04:55
06/28/17
06/28
04:55
06/28/17
04:55
General news
Breaking General news story  »

Week of 6/23 EIA…

NBIX

Neurocrine

$45.56

-1.75 (-3.70%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

LPI

Laredo Petroleum

$10.03

0.24 (2.45%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Laredo Petroleum management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MPWR

Monolithic Power

$96.84

-2.67 (-2.68%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Monolithic Power management to meet with Oppeneimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TRS

TriMas

$20.60

-0.1 (-0.48%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
TriMas management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ORCL

Oracle

$50.75

-0.11 (-0.22%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
Oracle management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

UNFI

United Natural Foods

$34.95

-0.08 (-0.23%)

04:55
06/28/17
06/28
04:55
06/28/17
04:55
Conference/Events
United Natural Foods management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 13

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.